Medprin Regenerative Medical Technologies Co (SZSE:301033) Days Sales Outstanding : 25.64 (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Medprin Regenerative Medical Technologies Co Days Sales Outstanding?

Medprin Regenerative Medical Technologies Co's average Accounts Receivable for the three months ended in Mar. 2024 was ¥16.1 Mil. Medprin Regenerative Medical Technologies Co's Revenue for the three months ended in Mar. 2024 was ¥57.2 Mil. Hence, Medprin Regenerative Medical Technologies Co's Days Sales Outstanding for the three months ended in Mar. 2024 was 25.64.

The historical rank and industry rank for Medprin Regenerative Medical Technologies Co's Days Sales Outstanding or its related term are showing as below:

SZSE:301033' s Days Sales Outstanding Range Over the Past 10 Years
Min: 14.71 Med: 17.79 Max: 64.66
Current: 15.92

During the past 7 years, Medprin Regenerative Medical Technologies Co's highest Days Sales Outstanding was 64.66. The lowest was 14.71. And the median was 17.79.

SZSE:301033's Days Sales Outstanding is ranked better than
96.17% of 810 companies
in the Medical Devices & Instruments industry
Industry Median: 64.2 vs SZSE:301033: 15.92

Medprin Regenerative Medical Technologies Co's Days Sales Outstanding increased from Mar. 2023 (17.28) to Mar. 2024 (25.64).

Medprin Regenerative Medical Technologies Co Days Sales Outstanding Historical Data

The historical data trend for Medprin Regenerative Medical Technologies Co's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medprin Regenerative Medical Technologies Co Days Sales Outstanding Chart

Medprin Regenerative Medical Technologies Co Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

14.88

17.79

15.50

14.71

22.52

Medprin Regenerative Medical Technologies Co Quarterly Data
	Dec18	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Days Sales Outstanding	Get a 7-Day Free Trial															17.28	12.39	11.05	14.94	25.64

Competitive Comparison of Medprin Regenerative Medical Technologies Co's Days Sales Outstanding

For the Medical Devices subindustry, Medprin Regenerative Medical Technologies Co's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medprin Regenerative Medical Technologies Co's Days Sales Outstanding Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Medprin Regenerative Medical Technologies Co's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Medprin Regenerative Medical Technologies Co's Days Sales Outstanding falls into.

Medprin Regenerative Medical Technologies Co Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Medprin Regenerative Medical Technologies Co's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (10.417	+	18.077)	/	2 )	/	230.87	*	365
=	14.247					/	230.87	*	365
=	22.52

Medprin Regenerative Medical Technologies Co's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding (Q: Mar. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2023 )	+	Accounts Receivable (A: Mar. 2024 ))	/	count )	/	Revenue (A: Mar. 2024 )	*	Days in Period
=	( (18.077	+	14.074)	/	2 )	/	57.206	*	365 / 4
=	16.0755					/	57.206	*	365 / 4
=	25.64

Medprin Regenerative Medical Technologies Co (SZSE:301033) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Medprin Regenerative Medical Technologies Co Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Medprin Regenerative Medical Technologies Co's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Medprin Regenerative Medical Technologies Co (SZSE:301033) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Medprin Regenerative Medical Technologies Co Ltd (SZSE:301033) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 80 Lanyue Road, 3rd Floor, Area E, High-tech Industrial Development Zone, Guangdong Province, Science City, Guangzhou, CHN, 510663

Website

https://www.medprin.com

Medprin Regenerative Medical Technologies Co Ltd is engaged in the development and manufacturing of high-performance implanted medical devices.

Medprin Regenerative Medical Technologies Co (SZSE:301033) Headlines

No Headlines